287289 A study found that liraglutide therapy in mice decreased visceral fat, which is associated with metabolic diseases, and relatively increased subcutaneous fat, with lipogenesis being suppressed or enhanced, respectively
Across all agents and doses, placebo-adjusted mean weight loss was 10.9 per cent, accompanied by a systolic blood pressure reduction of 5.2 millimetres of mercury
Trends in Plant Science
GLP-1 medications are an investment in your long-term health not just a short-term fix
the similar GIP/GLP-1 medication, tirzepatide (Mounjaro, Zepbound)
If youre wondering what kind of progress is realistic over the first several months of treatment, our guide on weight loss after three months on tirzepatide explains what many patients experience as treatment continues